PUBLICATION: VUMC Geriatric Psychiatry Researchers publish early report from multi-site REMBRANDT study examining relapse in recurrent late-life depression
January 14, 2025
This publication in Psychological Medicine is part of a collaboration between VUMC Department of Psychiatry and Behavioral Sciences and researchers at University of Pittsburgh, and University of Illinois-Chicago. This is an early report from the REMBRANDT study examining clinical and biological predictors of relapse in recurrent late-life depression
Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression
July 17, 2024
https://www.sciencedirect.com/science/article/pii/S0165032724010826?via%3Dihub=
A recent report from faculty and staff in the Vanderbilt Division of Geriatric Psychiatry demonstrates the potential benefit of adding transdermal nicotine patches to standard antidepressant medications for older adults with depression. The open-label study found that administration of nicotine patches safely resulted in improvement in mood and some measures of cognitive performance. This study supports that further work is needed, such as the ongoing placebo-controlled trial currently underway in the Vanderbilt Division of Geriatric Psychiatry.